This template has been developed in consultation with IPHA, HSE, NCCP and the NCPE. It is intended that the document be submitted to each unit, where relevant. The completed document is intended to enable the HSE, NCPE and NCCP to have an understanding of the lists of products for which pricing and / or reimbursement applications are expected to be made within the following 18 months. We request that companies submit the horizon scanning forms for the new medicines in their portfolio by the end of July each year, in accordance with the Framework Agreement 2021.
